全球儿童脑肿瘤生存趋势:2000-2014年61个国家67,776例患儿按组织学分析(CONCORD-3)
CONCORD-3研究纳入2000-2014年61个国家0-14岁脑肿瘤患儿67,776例,按12个组织学组估计净生存。低级别星形细胞瘤5年净生存全球范围为84%-100%,髓母细胞瘤在2010-2014年诊断患儿中为47%-86%。
要点
- 低级别星形细胞瘤年龄标化5年净生存全球范围为84%-100%(2000-2014年诊断)。
- 多数国家低级别星形细胞瘤5年生存率在2000-2004、2005-2009和2010-2014三个时段均达90%或以上。
- 髓母细胞瘤2010-2014年诊断患儿年龄标化5年净生存全球范围为47%-86%,差异更大。
核心结论
- 本研究为迄今最大规模的儿童脑肿瘤按组织学分类的人群生存趋势分析。
- 研究采用增强版ICCC-3以校正全球癌症登记实践差异。
- 低级别胶质瘤被WHO纳入全球儿童癌症倡议的6种指数儿童癌症之一,研究结果可能具有公共卫生意义。
研究设计与样本
- 基于人群的癌症登记分析(CONCORD-3),纳入2000-2014年诊断的0-14岁脑肿瘤患儿,不论肿瘤生物学行为。
- 数据经过严格的三阶段质量控制。
- 采用修订版国际儿童癌症分类第三版(ICCC-3)以控制非恶性星形细胞肿瘤漏登记。
- 使用无偏非参数Pohar Perme估计法估计净生存。
- 共纳入67,776例儿童,按12个组织学组估计生存,每组基于相关ICD-O-3编码。
主要发现
- 低级别星形细胞瘤年龄标化5年净生存全球范围在2000-2014年为84%-100%。
- 多数国家低级别星形细胞瘤5年生存率在2000-2004、2005-2009和2010-2014三个时段均为90%或以上。
- 髓母细胞瘤2010-2014年诊断患儿年龄标化5年净生存全球范围为47%-86%,全球差异更大。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Tumors of the central nervous system are among the leading causes of cancer-related death in children. Population-based cancer survival reflects the overall effectiveness of a health care system in managing cancer. Inequity in access to care world-wide may result in survival disparities. METHODS: We considered children (0-14 years) diagnosed with a brain tumor during 2000-2014, regardless of tumor behavior. Data underwent a rigorous, three-phase quality control as part of CONCORD-3. We implemented a revised version of the International Classification of Childhood Cancer (third edition) to control for under-registration of non-malignant astrocytic tumors. We estimated net survival using the unbiased nonparametric Pohar Perme estimator. RESULTS: The study included 67,776 children. We estimated survival for 12 histology groups, each based on relevant ICD-O-3 codes. Age-standardized 5-year net survival for low-grade astrocytoma ranged between 84% and 100% world-wide during 2000-2014. In most countries, 5-year survival was 90% or more during 2000-2004, 2005-2009, and 2010-2014. Global variation in survival for medulloblastoma was much wider, with age-standardized 5-year net survival between 47% and 86% for children diagnosed during 2010-2014. CONCLUSIONS: To the best of our knowledge, this study provides the largest account to date of global trends in population-based survival for brain tumors in children, by histology. We devised an enhanced version of ICCC-3 to account for differences in cancer registration practices world-wide. Our findings may have public health implications, because low-grade glioma is 1 of the 6 index childhood cancers included by WHO in the Global Initiative for Childhood Cancer.
引用
- Girardi F, Di Carlo V, Stiller C, et al. Global survival trends for brain tumors, by histology: Analysis of individual records for 67,776 children diagnosed in 61 countries during 2000-2014 (CONCORD-3). Neuro Oncol. 2023. PMID: 36215122. doi:10.1093/neuonc/noac232
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。